Phase
Condition
Genitourinary Prolapse
Labor/delivery
Treatment
Standard of Care (SOC)
Materna Prep Device
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Criteria for inclusion
- Subject is scheduled for vaginal birth.
- Subject is gestating a single fetus.
- Subject is nulliparous, or had a previous pregnancy terminated within 24 weeksgestation.
- Subject is able and willing to comply with the protocol required follow-up visits.
- Subject is able and willing to provide written informed consent prior to enrollment.
- In the opinion of the Investigator, the subject has sufficient mental capacity tounderstand the informed consent form (ICF), comply with the protocol requirements, andprovide clinically relevant and reliable feedback regarding their experience with thedevice.
- Subject receives epidural anesthesia during labor prior to enrollment.
- Subject is 18 years of age or older at time of consent.
Exclusion
Exclusion Criteria: Criteria for exclusion
- Subject has high likelihood of less than 1 hour of potential device dilation timeafter she arrives at the hospital.
- Subject is planning or requires a Caesarean-section prior to randomization.
- Subject begins labor with less than 36 weeks gestation.
- Subject has a neurological disorder that could cause pelvic floor dysfunction, such asmultiple sclerosis or spinal cord injury.
- Subject has a collagen-associated disorder that affects tissue elasticity, such asscleroderma or Ehlers-Danlos syndrome.
- Subject has a localized (genital tract) or systemic infection.
- Subject has a medical history which could lead to pelvic floor dysfunction, such asprior pelvic fractures, pelvic soft tissue injuries, or vaginal surgery.
- Subject has any general health condition or systemic disease that may represent, inthe opinion of the Investigator, a potential increased risk associated with device useor pregnancy.
- Subject has placenta previa or vasa previa.
- Subject has known significant chromosomal or structural fetal anomalies.
- Subject has a category 2 and/or 3 fetal tracing that is unresolved.
- Subject is observed to have friable, denuded, or markedly edematous vaginal tissueduring the course of labor.
Study Design
Study Description
Connect with a study center
University of Alabama at Birmingham
Birmingham, Alabama 35233
United StatesSite Not Available
MarinHealth/La Follette Ob-Gyn and Aesthetics
Greenbrae, California 94904
United StatesSite Not Available
University of California Los Angeles
Los Angeles, California 90095
United StatesActive - Recruiting
El Camino Hospital
Mountain View, California 94040
United StatesSite Not Available
Christiana Care - Center for Women's & Children's Health
Newark, Delaware 19718
United StatesActive - Recruiting
Mayo Clinic
Rochester, Minnesota 55905
United StatesSite Not Available
The Cooper Health System
Camden, New Jersey 08103
United StatesActive - Recruiting
Rutgers Robert Wood Johnson University Hospital
New Brunswick, New Jersey 08901
United StatesActive - Recruiting
Rutgers New Jersey Medical School
Newark, New Jersey 07103
United StatesActive - Recruiting
Columbia University Irving Medical Center
New York, New York 10032
United StatesActive - Recruiting
The Metro Health System
Cleveland, Ohio 44109
United StatesActive - Recruiting
The Ohio State University Wexner Medical Center
Columbus, Ohio 43210
United StatesActive - Recruiting
Oregon Health and Science University
Portland, Oregon 97239
United StatesTerminated
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania 19140
United StatesActive - Recruiting
Lewis Katz School of Medicine at Temple
Philadelphia, Pennsylvania 19140
United StatesSite Not Available
Baylor College of Medicine
Houston, Texas 77030
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.